NanoViricides Inc. (NNVC)

[changes_iv]

Thanks Puffer for your detailed explanation. I chopped my ideas at the end of my post because I realized it would be a quite tight schedule.

Is it possible FDA has streamlined this process to the clinical trials? After all, FluCide (nanoviricides) is not just effective but has proven its low-toxicity.

Is it possible that this vehicle to the clinical trials has more than one speed? What if early on the efficacy and toxicology studies there are provision(s) (just like the clinical trials) to stop studies (for good and exceptional reasons)and go to report. That once reports are received by NanoViricides, Inc., Australian Biologics consulting firm jumps into action to coordinate the regulatory review and approval for the first human trials in Australia for Flucide. All this for good reasons. That FDA will follow suit and further accelerate approval to clinical trials, all in all, before December 2014.

Perhaps the provisions are not there yet but if not this time with FluCide they will be there for the other nanoviricides that will follow FluCide.

Regardless of all my speculation, we are finally moving with certainty, at a fast pace and NanoViricides, Inc. CEO, Dr. Seymour can unequivocally state that we will be awaiting for permission to start human trials this year, 2014.